T 1820/18 (LRP6 binding molecules/NOVARTIS) of 17.12.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T182018.20211217
- Date of decision
- 17 December 2021
- Case number
- T 1820/18
- Petition for review of
- -
- Application number
- 08844924.4
- IPC class
- C07K 16/28A61P 35/00A61K 39/395
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (LRP6)
- Applicant name
- Novartis AG
- Opponent name
- Boehringer Ingelheim RCV GmbH & Co KG /
Boehringer Ingelheim International GmbH (Opposition withdrawn)
Merck Patent GmbH - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(c)European Patent Convention Art 123(2)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Grounds for opposition - added subject-matter (yes)
Amendments - added subject-matter (yes)
Amendment after summons - exceptional circumstances (no)
Amendment after summons - cogent reasons (no)
Amendment after summons - taken into account (no) - Catchword
- -
Order
For these reasons it is decided that:
1. The appeal is dismissed.